Gemst

a functional mixture of compounds (amino acids and derivatives, fatty acids, and vitamins) linked to poly-L-lysine; reverses pathologic changes following ischemic stroke in animal models

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Coveñas, Rafael: 1 article (05/2017)
2.	Geffard, Michel: 1 article (05/2017)
3.	González, Noelia: 1 article (05/2017)
4.	Mangas, Arturo: 1 article (05/2017)
5.	Pernìa, Marianny: 1 article (05/2017)
6.	Ruiz, Isabel: 1 article (05/2017)
7.	Yajeya, Javier: 1 article (05/2017)

Related Diseases

1.	Stroke (Strokes) 05/25/2017 - "Gemst could be a new drug for the treatment of stroke since it reverses the pathological findings of stroke and normalizes brain tissue conditions following the ischemic insult." 05/25/2017 - "Gemst reversed the pathological conditions of stroke to normal situations. " 05/25/2017 - "In the early phase (3 and 5 days of the stroke, we observed no effect of Gemst treatment (7.5 mg/day, subcutaneously for 3, 5 days). " 05/25/2017 - "Gemst: a taylor-made combination that reverts neuroanatomical changes in stroke." 05/25/2017 - "In a single transient middle cerebral artery occlusion model of stroke and using immunohistochemical techniques, the effects of a new therapeutic approach named Gemst (a member of the Poly-L-Lysine innovative therapies) have been studied in the rat brain. "
2.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/25/2017 - "In a single transient middle cerebral artery occlusion model of stroke and using immunohistochemical techniques, the effects of a new therapeutic approach named Gemst (a member of the Poly-L-Lysine innovative therapies) have been studied in the rat brain. "
3.	Gliosis 05/25/2017 - "Gemst exerts a multifunctional action: down-regulates the indoleamine 2, 3-dioxygenase pathway and abolishes brain infiltration, microglial activation and gliosis. "

Related Drugs and Biologics

1.	Dioxygenases
2.	Lysine (L-Lysine)

Related Therapies and Procedures

1.	Investigational Therapies (Experimental Therapy)